Matina Chief Medical News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Matinas BioPharma Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides

In an acute colitis model, data show statistically significant knockdown of elevated levels of serum TNFα, reductions in tissue TNFα mRNA and improvement in disease activity scores In an acute.

United statesJody cainJeromed jabbourMatinas biopharmaJames fergusonMatinas biopharma holdings incBiopharma holdingsMatina chief medicalColitis studyPsoriasis studyChief executive officerPrivate securities litigation reform act

Matinas BioPharma (MTNB) Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides

Matinas BioPharma (MTNB) Demonstrates in vivo Biological Activity and Disease Improvement in Two Inflammatory Disease Models with Oral LNC-Delivered Small Oligonucleotides
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJames fergusonMatinas biopharma holdings incMatinas biopharma holdingsMatina chief medical